(In Spanish) Inhibir una molécula llamada TGF-beta permite que algunos cánceres de difícil tratamiento respondan a la inmunoterapia, según dos investigaciones que se presentan esta semana en la revista Nature. Sus resultados cambian la visión de cómo los tumores se evaden del sistema inmunitario y abren la vía a mejorar la terapia del cáncer colorrectal –el más frecuente en España- y de otros tumores. Source: http://www.lavanguardia.com/ciencia/20180214/44782658824/inmunoterapia-esperanza-cancer-colon-tgf-beta.html
An international group of scientists has produced the first atlas that shows how the activity of genes in each organ of the human body is regulated. The catalog, which the consortium has made public on the internet, is a powerful tool to study diseases from a genetic point of view. See full story in La Vanguardia.
17Source: Med Devide Online A team of university scientists has developed the world’s first artificial kidney technology to be implanted in the body. Their bio-hybrid approach uses living kidney cells in tandem with a series of specialized microchips powered by the human heart to filter waste from the blood stream. The National Kidney Foundation estimates that over 100,000 patients are on the waiting list for a…
According to Chinese CCTV television, a team of scientists and engineers from the Chinese Academy of Engineering has been working with a 3D bio-printer to create artificial blood vessels. At the moment some of these artificial creations have been implanted to 30 Rhesus monkeys and after the surgeries they have verified that they function like the natural ones. The full story on Microsiervos.
Despite the differences in the methodology used by laboratories, the results are very similar An article in Nature Biotechnology involving experts of Programa de Epigenética y Biología del Cáncer del Instituto de Investigaciones Biomédicas de Bellvitge (Idibell) shows that epigenetic tests have the same technical quality and thoroughness that genetic testing. Although previous studies have already identified the quality of epigenetic tests, “this is the first…
On 24 and 25 November 2016 will be held in Zaragoza VII Congress of the Spanish Association of Prenatal Diagnosis. More information on their website.
From 18 to October 22 2016 will be held in Vancouver “ASHG 2016”. More information on their website.
From 27 to May 30 2017 will be held in Copenhagen “The European Human Genetics Conference 2017”. More information on their website.
Ferrer and IDIBELL develop EPICUP, the first epigenetic test for patients with cancer of unknown origin
Ferrer pharmaceutical company, with headquarters in Barcelona, announced the launch of EPICUP, the first epigenetic diagnostic test based on the analysis of DNA methylation profiles and helps the oncologist to identify the primary tumor in patients with cancer of unknown origin (CUP). The tool, fruit of public-private partnership between the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL) led by…
From 21 to May 24 will be held in Barcelona on “European Meeting on Psychosocial Aspects of Genetics 2016”. More information on their website.